Is TCF7L2 useful for menopause?

TCF7L2 is primarily associated with type 2 diabetes risk, not directly with menopause. Menopause is a hormonal process driven by estrogen decline, and there is no strong evidence that TCF7L2 variants significantly influence menopause timing or symptoms like hot flashes or weight gain. Some research explores links between diabetes risk and metabolic changes during menopause, but effect sizes are small and not clinically actionable. Consumer DNA tests that market TCF7L2 in the context of menopause often overstate its relevance. For menopause management, hormone levels, lifestyle, and family history are far more important than a single gene. Evidence grade: unclear / marketing. Caveat: TCF7L2 testing may be useful for diabetes risk assessment, but not for menopause guidance.